Novacyt half year 2018 results Paris, France and Camberley, UK – 26 September 2018 – Novacyt (ALTERNEXT: ALNOV; AIM: NCYT), an international specialist in clinical diagnostic products, today announces unaudited financial results for the six months ended 30 June 2018.
Visit PageYear: 2018
NOVACYT PARTNERS WITH APPLIED MICROARRAYS IN ASSAY DESIGN
Novacyt partners with Applied Microarrays US partnership to facilitate the design and optimisation for customised microarray assays
Visit PageHalf Year Revenue Update Primerdesign revenues up 18% to €3m Strong pipeline of B2B and tender prospects Decision to undertake a strategic review of the NOVAprep® business
Trading update for six months to 30 June 18 Paris, France and Camberley, UK – 2 August 2018 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces an unaudited half year revenue update for the six months to 30 June 2018.
Visit Page